Published in BMC Res Notes on September 02, 2014
Development of a new choroidal metastasis in resistance to crizotinib therapy in anaplastic lymphoma kinase-rearranged non-small cell lung cancer. Int J Ophthalmol (2017) 0.75
Successful Treatment with Alectinib for Choroidal Metastasis in Anaplastic Lymphoma Kinase Rearranged Non-small Cell Lung Cancer. Intern Med (2017) 0.75
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol (2011) 6.69
CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib. J Clin Oncol (2011) 3.00
Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. Anticancer Drugs (2007) 2.08
Rapid response of brain metastasis to crizotinib in a patient with ALK rearrangement-positive non-small-cell lung cancer. J Thorac Oncol (2013) 1.15
Long-lasting response to crizotinib in brain metastases due to EML4-ALK-rearranged non-small-cell lung cancer. BMJ Case Rep (2013) 1.05
Ineffectiveness of crizotinib on brain metastases in two cases of lung adenocarcinoma with EML4-ALK rearrangement. J Thorac Oncol (2013) 1.04
Choroidal metastases responsive to crizotinib therapy in a lung adenocarcinoma patient with ALK 2p23 fusion identified by ALK immunohistochemistry. J Thorac Oncol (2013) 0.88
Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters. Expert Opin Drug Metab Toxicol (2013) 0.84
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Engl J Med (2007) 3.97
Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med (2003) 2.35
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol (2005) 2.20
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood (2006) 2.09
Cancer survivorship: Is there a role for cancer survivor clinics? Cancer (2014) 2.01
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials. Blood (2004) 1.91
Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol (2009) 1.60
Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study. Onkologie (2009) 1.58
Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis. Haematologica (2008) 1.54
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol (2003) 1.45
Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma. Blood (2008) 1.43
Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection. AIDS (2003) 1.40
Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. J Mol Diagn (2005) 1.37
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer. Lung Cancer (2009) 1.30
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. J Clin Oncol (2006) 1.23
Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist (2011) 1.14
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood (2013) 1.13
Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol (2002) 1.10
High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol (2003) 1.09
Recurrence of breast cancer in elderly women. J Clin Oncol (2013) 1.08
Beyond semantics: the need to better categorize patients with cancer. J Clin Oncol (2013) 1.05
Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer (2003) 1.03
Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma. Haematologica (2007) 1.02
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood (2002) 1.02
AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies. Curr HIV Res (2009) 1.00
Genome wide DNA-profiling of HIV-related B-cell lymphomas. Br J Haematol (2009) 0.97
The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma. Int J Cancer (2008) 0.97
Treatment of head and neck cancer in elderly patients: state of the art and guidelines. Crit Rev Oncol Hematol (2005) 0.97
Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma. Clin Infect Dis (2010) 0.96
Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist (2012) 0.95
Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy. Clin Infect Dis (2003) 0.95
Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature. Hum Pathol (2009) 0.91
Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection. Clin Infect Dis (2003) 0.91
Therapeutic approaches to AIDS-related malignancies. Oncogene (2003) 0.91
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience. BMC Res Notes (2012) 0.90
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas. Br J Haematol (2009) 0.90
The role of nutrition in the development of esophageal cancer: what do we know? Front Biosci (Elite Ed) (2012) 0.89
Stem cell transplantation for lymphoma patients with HIV infection. Cell Transplant (2010) 0.89
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas. Br J Haematol (2011) 0.87
A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin. Mod Pathol (2006) 0.87
Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother (2002) 0.86
What elderly cancer patients want to know? Differences among elderly and young patients. Psychooncology (2007) 0.86
Trends in cancer incidence rates among HIV-infected patients. Clin Infect Dis (2005) 0.86
Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion. Eur J Haematol (2007) 0.86
Stem cell mobilization in HIV seropositive patients with lymphoma. Haematologica (2013) 0.85
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study. J Clin Oncol (2006) 0.85
Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study. Lung Cancer (2007) 0.85
Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome. J Clin Virol (2012) 0.84
Adjuvant radiotherapy on older and oldest breast cancer patients after conservative surgery: a retrospective analysis. Arch Gerontol Geriatr (2011) 0.84
Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma. Br J Haematol (2012) 0.83
Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma. Clin Infect Dis (2003) 0.83
Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients. Oncologist (2013) 0.83
Anal cancer: Focus on HIV-positive patients in the HAART-era. Curr HIV Res (2011) 0.83
The role of diet in gastric cancer: still an open question. Front Biosci (Landmark Ed) (2012) 0.83
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials. Clin Lymphoma Myeloma (2005) 0.83
Time trends of cancer mortality among elderly in Italy, 1970-2008: an observational study. BMC Cancer (2012) 0.81
Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy. Clin Infect Dis (2005) 0.81
Hodgkin's Disease in Patients with HIV Infection. Adv Hematol (2010) 0.81
Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer (2010) 0.81
Insight into the treatment of cancer in older patients: developments in the last decade. Cancer Treat Rev (2006) 0.81
Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients. Anticancer Drugs (2013) 0.81
Therapeutic options for HIV-associated lymphomas. Expert Opin Pharmacother (2010) 0.81
Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome. Am J Hematol (2011) 0.81
FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study. Arch Gerontol Geriatr (2010) 0.81
Cancer-related fatigue (review). Int J Oncol (2002) 0.81
Comprehensive geriatric evaluation in elderly patients with lymphoma: feasibility of a patient-tailored treatment plan. J Clin Oncol (2003) 0.80
Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. J Clin Oncol (2006) 0.80
HIV-infected patients and liver transplantation: who, when and why. Curr HIV Res (2011) 0.80
Predictive value of HIV type 1 DNA levels on overall survival in HIV-related lymphoma Patients treated with high-dose chemotherapy (HDC) plus autologous stem cell transplantation (ASCT). AIDS Res Hum Retroviruses (2010) 0.80
Hepatocellular carcinoma: beyond the boundaries of age. Anticancer Agents Med Chem (2013) 0.80
Combined 50- and 20-MHz frequency ultrasound imaging in intermediate uveitis. Am J Ophthalmol (2006) 0.80
Bevacizumab plus irinotecan-, fluorouracil-, and leucovorin-based chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer. Onkologie (2008) 0.80
Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma. Leuk Lymphoma (2011) 0.79
Cancer in the elderly: the caregivers' perception of senior patients' informational needs. Arch Gerontol Geriatr (2008) 0.79
Role of the HLA class II: HCV-related disorders. Ann N Y Acad Sci (2007) 0.79
Elderly head and neck (H-N) cancer patients: a monoinstitutional series. Tumori (2002) 0.79
Management of immunocompetent patients with primary central nervous system lymphoma. Clin Lymphoma Myeloma (2009) 0.79
Biomarkers in neuroendocrine tumors. Front Biosci (Schol Ed) (2010) 0.79
An overview of viral oncology in Italy - report from the Pavia meeting on solid tumors. Infect Agent Cancer (2012) 0.78
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. J Clin Oncol (2007) 0.78
Unusual presentation of metastatic hepatocellular carcinoma in an HIV/HCV coinfected patient: case report and review of the literature. Tumori (2008) 0.78
The revised piper fatigue scale (PFS-R) for Italian cancer patients: a validation study. Tumori (2010) 0.78
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma. Hematol Oncol (2012) 0.78
Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients. Anticancer Agents Med Chem (2013) 0.78
Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: a potential role of interleukin-7. Cytokine (2012) 0.78
Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era. J Clin Oncol (2005) 0.78
Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis. Br J Haematol (2002) 0.78
Autograft HIV-DNA load predicts HIV-1 peripheral reservoir after stem cell transplantation for AIDS-related lymphoma patients. AIDS Res Hum Retroviruses (2015) 0.78
Biological and clinical markers in colorectal cancer: state of the art. Front Biosci (Schol Ed) (2010) 0.78
Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res (2010) 0.78
Hodgkin's disease in HIV. Hematol Oncol Clin North Am (2003) 0.78
HIV-positive patients with liver metastases from colorectal cancer deserve the same therapeutic approach as the general population. Onkologie (2010) 0.77
Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1. Am J Pathol (2002) 0.77
Colorectal cancer in elderly patients: from best supportive care to cure. Anticancer Agents Med Chem (2013) 0.77
Prognostic factors in human herpesvirus 8-related lymphoproliferative disorders associated with HIV infection. J Clin Oncol (2006) 0.77